211 related articles for article (PubMed ID: 21775206)
1. Notch in T-ALL: new players in a complex disease.
Koch U; Radtke F
Trends Immunol; 2011 Sep; 32(9):434-42. PubMed ID: 21775206
[TBL] [Abstract][Full Text] [Related]
2. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
3. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
4. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.
Grabher C; von Boehmer H; Look AT
Nat Rev Cancer; 2006 May; 6(5):347-59. PubMed ID: 16612405
[TBL] [Abstract][Full Text] [Related]
5. Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition.
Szczepanski T; van der Velden VH; Waanders E; Kuiper RP; Van Vlierberghe P; Gruhn B; Eckert C; Panzer-Grümayer R; Basso G; Cavé H; Stadt UZ; Campana D; Schrauder A; Sutton R; van Wering E; Meijerink JP; van Dongen JJ
J Clin Oncol; 2011 Apr; 29(12):1643-9. PubMed ID: 21357790
[TBL] [Abstract][Full Text] [Related]
6. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
Pear WS; Aster JC
Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
[TBL] [Abstract][Full Text] [Related]
7. Dynamic regulation of notch 1 and notch 2 surface expression during T cell development and activation revealed by novel monoclonal antibodies.
Fiorini E; Merck E; Wilson A; Ferrero I; Jiang W; Koch U; Auderset F; Laurenti E; Tacchini-Cottier F; Pierres M; Radtke F; Luther SA; Macdonald HR
J Immunol; 2009 Dec; 183(11):7212-22. PubMed ID: 19915064
[TBL] [Abstract][Full Text] [Related]
8. Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL.
Gusscott S; Kuchenbauer F; Humphries RK; Weng AP
Leuk Res; 2012 Jul; 36(7):905-11. PubMed ID: 22424712
[TBL] [Abstract][Full Text] [Related]
9. Early T cell differentiation lessons from T-cell acute lymphoblastic leukemia.
Tremblay CS; Hoang T; Hoang T
Prog Mol Biol Transl Sci; 2010; 92():121-56. PubMed ID: 20800819
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines.
Dohda T; Maljukova A; Liu L; Heyman M; Grandér D; Brodin D; Sangfelt O; Lendahl U
Exp Cell Res; 2007 Aug; 313(14):3141-52. PubMed ID: 17560996
[TBL] [Abstract][Full Text] [Related]
11. Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia.
González-García S; García-Peydró M; Alcain J; Toribio ML
Curr Top Microbiol Immunol; 2012; 360():47-73. PubMed ID: 22695916
[TBL] [Abstract][Full Text] [Related]
12. Loss of T-cell quiescence by targeting Slfn2 prevents the development and progression of T-ALL.
Goldshtein A; Zerbib SM; Omar I; Cohen-Daniel L; Popkin D; Berger M
Oncotarget; 2016 Jul; 7(30):46835-46847. PubMed ID: 27206675
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises.
Sarmento LM; Barata JT
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1403-15. PubMed ID: 21929314
[TBL] [Abstract][Full Text] [Related]
14. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
[TBL] [Abstract][Full Text] [Related]
15. Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice.
Mantha S; Ward M; McCafferty J; Herron A; Palomero T; Ferrando A; Bank A; Richardson C
Leuk Res; 2007 Mar; 31(3):321-7. PubMed ID: 16870249
[TBL] [Abstract][Full Text] [Related]
16. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia.
Van Vlierberghe P; Pieters R; Beverloo HB; Meijerink JP
Br J Haematol; 2008 Oct; 143(2):153-68. PubMed ID: 18691165
[TBL] [Abstract][Full Text] [Related]
17. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
Asnafi V; Ferrier P
Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
[No Abstract] [Full Text] [Related]
18. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.
Vilimas T; Mascarenhas J; Palomero T; Mandal M; Buonamici S; Meng F; Thompson B; Spaulding C; Macaroun S; Alegre ML; Kee BL; Ferrando A; Miele L; Aifantis I
Nat Med; 2007 Jan; 13(1):70-7. PubMed ID: 17173050
[TBL] [Abstract][Full Text] [Related]
19. Kick it up a Notch: NOTCH1 activation in T-ALL.
Gridley T
Cancer Cell; 2004 Nov; 6(5):431-2. PubMed ID: 15542425
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia.
Paganin M; Ferrando A
Blood Rev; 2011 Mar; 25(2):83-90. PubMed ID: 20965628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]